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Abstract
Bovine mastitis is a costly disease in dairy cattle worldwide. As of yet, the control of bovine
mastitis is mostly based on prevention by thorough hygienic procedures during milking.
Additional strategies include vaccination and utilization of antibiotics. Despite these mea-
sures, mastitis is not fully under control, thus prompting the need for alternative strategies.
The goal of this study was to isolate autochthonous lactic acid bacteria (LAB) from bovine
mammary microbiota that exhibit beneficial properties that could be used for mastitis pre-
vention and/or treatment. Sampling of the teat canal led to the isolation of 165 isolates,
among which a selection of ten non-redundant LAB strains belonging to the genera Lacto-
bacillus and Lactococcus were further characterized with regard to several properties: sur-
face properties (hydrophobicity, autoaggregation); inhibition potential of three main mastitis
pathogens, Staphylococcus aureus, Escherichia coli and Streptococcus uberis; coloniza-
tion capacities of bovine mammary epithelial cells (bMEC); and immunomodulation proper-
ties. Three strains, Lactobacillus brevis 1595 and 1597 and Lactobacillus plantarum 1610,
showed high colonization capacities and a medium surface hydrophobicity. These strains
are good candidates to compete with pathogens for mammary gland colonization. More-
over, nine strains exhibited anti-inflammatory properties, as illustrated by the lower IL-8
secretion by E. coli-stimulated bMEC in the presence of these LAB. Full genome sequenc-
ing of five candidate strains allowed to check for undesirable genetic elements such as anti-
biotic resistance genes and to identify potential bacterial determinants involved in the
beneficial properties. This large screening of beneficial properties while checking for
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Introduction
Bovine mastitis is an inflammation of the mammary gland and most often results from bacte-
rial infection. These intramammary infections cause huge economic losses in the dairy farming
sector and dairy industry [1,2]. To date, the treatment of bovine mastitis is predominantly
based on antibiotics. However, they are not totally effective and contribute to the emergence
and transmission of antibiotic resistance within the host microbiota, which include both com-
mensals and opportunistic pathogens. There is thus a need for alternative strategies that can be
used as prophylactic or alternative or complementary curative treatments.
One alternative is the emerging concept of mammary probiotics. For this purpose, lactic
acid bacteria (LAB) are good candidates due to their Generally Recognized As Safe (GRAS) sta-
tus and their recognized technological and inhibitory properties. LAB have been investigated
for many years for their beneficial effects on human health [3,4]. They contribute to maintain-
ing the balance of natural microbiota (i.e., vaginal and gut), by competing with pathogens for
tissue colonization, modulating virulence expression or stimulating the innate immune system
[5,6]. Probiotics have also been shown to be an effective alternative to antibiotherapy for the
treatment of human mastitis [7].
Likewise, the use of probiotics has gained interest in the veterinary community. The autoch-
thonous bovine mammary microbiota was investigated, either by isolation on selective culture
media or by 16S rRNA sequencing to identify microorganisms with inhibitory properties
against mastitis pathogens [8]. A bacteriocin-producing Lactococcus lactis was shown to be as
effective in vivo as a conventional antibiotic treatment to treat cow mastitis [9]. Encouraging
results were also obtained in vitro with a strain of Lactobacillus perolens, which was shown to
inhibit several mastitis-causing pathogens as a result of its coaggregation with mastitis patho-
gens and its capacity to colonize bovine mammary epithelial cells (bMEC) [10]. When used in
in vivo intramammary injections, this strain did not show adverse effects on mammary tissue
[11]. Similarly, we recently demonstrated in vitro that different Lactobacillus casei strains,
including one strain isolated from the bovine teat canal, inhibit adhesion and internalization of
S. aureus within bMEC without affecting the bMEC physiology [12].
Based on these observations, the objective of this study was to isolate LAB from bovine
mammary gland microbiota and to characterize their beneficial properties in order to select
good candidates to be included in a mammary probiotic cocktail against infectious mastitis. As
beneficial properties, we first evaluated LAB capacities to inhibit growth of the three main
pathogens associated with mastitis, i.e., Staphylococcus aureus, Escherichia coli and Streptococ-
cus uberis, through acidification and production of hydrogen peroxide and bacteriocin-like
compounds [13]. Secondly, we characterized their surface properties including their autoaggre-
gation capacities and their degree of hydrophobicity, which have been associated with the abil-
ity to colonize host tissues [14]. Thirdly, we investigated LAB capacities to adhere to bMEC
(MAC-T cell line) in order to estimate their potential to colonize the mammary gland epithe-
lium in vivo and, as a consequence, to compete with pathogens for tissue colonization. Finally,
their ability to stimulate the innate immune system was estimated by measuring their capacity
to modulate production of a pro-inflammatory cytokine (IL-8) by the bMEC line PS. IL-8 is
involved in the first steps of the inflammatory response of the mammary gland, leading to
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neutrophil recruitment [15]. The full sequencing of five out of ten strains was included so as to
identify potential genomic determinants of the colonization and immunomodulation capacities
and to check for undesirable or unfavorable genetic elements, e.g., antibiotic resistance deter-
minants. This characterization allowed us to identify promising LAB strains that exhibited a
good potential to colonize the mammary gland ecosystem, as well as immunomodulation
properties.
Materials and Methods
Sampling
The samples were collected from 20 Holstein dairy cows in two herds belonging to the Inter-
BioBretagne network (organic farming organization), in the Brittany region of France. One
quarter per cow was sampled, corresponding to the left or right rear quarter. Only quarters
without any clinical symptoms of mastitis were selected. Teats were thoroughly washed with
water and cleaned with 70% ethanol and individual paper towels. Teat canals were then sam-
pled in two different ways. A 5-mm sterile Histobrush1 swab (D. Dutscher, Brumath, France)
was inserted 5 mm inside the teat apex and turned three times before removal. The swabs were
immediately placed in tubes containing 2 mL of sterile peptone solution (20 g/L peptone; 5 g/L
sodium chloride). Foremilk samples were then collected in sterile plastic tubes. All samples
were stored on ice until processing in the laboratory.
The protocol was reviewed and approved by the Regional Ethics Committee for Animal Use
and Care (Bretagne, France). Sampling is part of a classical veterinary practice. According to
the European directive 2010 / 63 / EU, this type of experiment does not require an authoriza-
tion request. All persons involved in sampling the cows used in this study were licensed veteri-
narians. All procedures were part of routine care or surveillance. Permission was received from
the owners of the cattle to conduct and publish this research. No animals were sacrificed for
the purpose of this study.
Isolation of LAB strains
Foremilk samples were homogenized with nine volumes of a trisodium citrate solution (2%
w/v) and centrifuged (6650 g/5 min/4°C). The pellet was then suspended in 2 mL of sterile pep-
tone solution. Bacterial suspensions corresponding to swab and foremilk samples were grown
on M17, MRS or MRS 5.4 by diluting 100 μL of bacterial suspension in 12 mL of M17, MRS at
pH 6.8 and MRS broth acidified at pH 5.4 (hereafter referred to as MRS 5.4; more selective for
lactobacilli), followed by a 48-h incubation at 37°C in an anaerobic jar, for selective cultivation.
Serial dilutions of the enriched bacterial suspensions were then performed, plated on M17,
MRS and MRS 5.4, and incubated for 48 h at 37°C in an anaerobic jar. Colonies with different
morphotypes were isolated and set in collection in the enrichment medium supplemented with
15% glycerol and stored at -80°C.
Genetic identification of isolates
Each isolate was identified by sequencing the 16S rDNA gene. Genomic DNA was isolated
from a 2-mL overnight culture on M17, MRS or MRS 5.4 after centrifugation (6000 g/5 min/
4°C), washing with 1 mL of peptone solution, and an additional centrifugation (6000 g/5 min/
4°C). The pellet was lysed for 45 min at 37°C in 180-μL lysis buffer containing 20 mM Tris-
HCl (pH 8), 2 mM EDTA, 1% triton X100 and 20 g/L lysozyme (MP Biomedicals, Illkirch,
France). Genomic DNA was purified using the DNeasy1 Blood & Tissue Mini Kit (Qiagen,
Courtaboeuf, France), according to the manufacturer’s recommendations.
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PCR amplification of 16S rDNA was performed using a Veriti™ 96-well thermal cycler
(Applied Biosystems, Foster City, CA, USA) in a 50-μL final volume containing 20 ng genomic
DNA, 1x HF Phusion buffer, 0.5 μM of primers W001 (5’-AGAGTTTGATCMTGGCTC) and
W002 (5’-GNTACCTTGTTACGACTT)[16], 200 μM dNTP and 1U Phusion polymerase
(New England Biolabs). The PCR conditions were as follows: denaturation step at 95°C for 5
min, followed by 30 cycles of denaturation at 95°C for 30 s, annealing at 50°C for 30 s, and
extension at 72°C for 1 min 30 s. A final extension step was performed for 10 min at 72°C.
Sequencing of the PCR product was performed by LGC Genomics (Berlin, Germany) using the
same primers. Sequences were further compared to Genbank Database using BLAST. Identifi-
cation was achieved at specie level for similarity higher that 98%. When similarity search gave
the same score with several species, isolates were identified at the genus level.
The 22 LAB strains retained for PFGE analysis (see results) have been registered in the col-
lection of the CIRM-BIA Biological Resource Center (Rennes, France).
Characterization of LAB isolates by pulse-field gel electrophoresis
The PFGE molecular fingerprints of LAB isolates were obtained using the method adapted
from Smith and Cantor [17]. The culture and the agarose blocks were prepared as previously
described [18]. The blocks were equilibrated for one hour in a restriction buffer at 4°C and
transferred to 300 μL of fresh digestion buffer containing 15 U of SmaI or 25 U of AscI endo-
nucleases (New England Biolabs, Hitchin, UK). The blocks were incubated for 4 h at 25°C for
SmaI and at 37°C for AcsI. PFGE was carried out with a CHEF-DR II apparatus (Bio-Rad,
Australia) in a 1% agarose gel (w/v) (Ultrapur, Gibco-BRL, Scotland) in 0.5 × TBE at 200 V
and at 14°C with the following pulse times and total running time: SmaI (initial time—2 s;
final time—20 s; total running time—20 h), AscI (2 s; 20 s; 21 h). After electrophoresis, gels
were stained with GelRed and visualized under UV light. Photographs of PFGE gels were
scanned and the band profiles were analyzed using BioNumerics, version 4.1 (Applied
Maths, Kortrijk, Belgium). Comparisons between the normalized band profiles were made
using the Dice similarity coefficient with an optimization of 1%. Clustering of strain profiles
was accomplished using the unweighted pair group method with arithmetic averages
(UPGMA).
Production of hydrogen peroxide
Screening of hydrogen peroxide production by the isolates was performed using a TMB (3, 3’,
5, 5’-tetramethylbenzidine) assay, as previously described [8]. Strains were classified according
to the color intensity as non-producers, low producers or high producers of H2O2.
Production of antagonistic substances
The screening of the antimicrobial potential of the LAB supernatants was carried out using the
agar plate diffusion method as previously described [19]. Supernatants were either native, neu-
tralized with NaOH or neutralized and treated with 1000 U/mL of catalase (Sigma Aldrich,
USA) for 1 h at 25°C. Six pathogenic strains corresponding to the main species responsible for
bovine mastitis were used as indicators: Staphylococcus aureus RF122 and Newbould 305
(N305), which were isolated from bovine mastitis [20,21], Streptococcus uberis LMA1675 and
LMA1672, and Escherichia coli LMA1678 and LMA1674. S. uberis and E. coli strains were iso-
lated from the mammary ecosystem during this study.
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Bacterial surface properties
Autoaggregation capacities (i.e., the capacity of a strain to form aggregates in a bacterial sus-
pension) were determined as previously described [8]. The degree of hydrophobicity was evalu-
ated using the Microbial Adhesion To Hydrocarbons (MATH) method with hexadecane
(Sigma Aldrich, US) [8]. Strains were classified as low, medium and high, according to their
hydrophobicity or autoaggregative capacities.
Adhesion and internalization assays
The established bMECMAC-T line (Nexia Biotechnologies, Quebec, Canada) was cultured in
T75 cell culture flasks in DMEM containing 10% heat-inactivated fetal calf serum (FCS), 100
U/mL penicillin, 10 mg/mL streptomycin, and 5 μg/mL insulin (D. Dutscher). Cells were incu-
bated at 37°C in a humidified incubator with 5% CO2. They were cultured to a confluent
monolayer, treated with 0.05% trypsin (Gibco-BRL, Grand Island, NY, USA), and suspended
in fresh MAC-T medium at a concentration of 2x105 cells/mL. For adhesion and internaliza-
tion assays, cells were then seeded in 12-well plates (2x105 cells/well) and incubated overnight
at 37°C in 5% CO2 to obtain a confluent monolayer.
Adhesion assay. Adhesion assays were performed at least three times, as previously
described [12]. Briefly, confluent monolayers of MAC-T cells (2.5x105 cells/well) were washed
twice with PBS and incubated at 37°C in 5% CO2 with 1 mL of LAB suspensions in DMEM at
1x108 cfu/mL or 5x108 cfu/mL to achieve a multiplicity of infection (MOI) of LAB organisms
to cells of 400:1 and 2000:1, respectively. LAB adhesion was measured 1 h post-interaction.
After washing four times with PBS, the monolayer was treated with 0.05% trypsin, centrifuged
for 5 min at 800 g and lysed with 0.01% triton. The population of LAB that adhered to the cells
was determined by colony counting, on M17 agar for lactococci and MRS agar for lactobacilli,
from serial dilutions of the cell lysates.
Internalization assays. Internalization assays were performed at least three times in the
same conditions as adhesion assays (same MOI) except that LAB internalization was measured
2 h post-interaction. Following incubation with LAB, cells were washed four times with PBS
and incubated for 2 h with 1 mL of DMEM containing 100 μg/mL gentamicin in order to kill
extracellular bacteria and allow the numeration of the internalized bacterial population only.
Subsequently, cells were lysed and the population of internalized LAB was determined as
described above.
Immunomodulation properties of LAB strains on the PS cell line
The immunomodulation properties of LAB strains were evaluated by measuring the produc-
tion of the pro-inflammatory cytokine IL-8, a cytokine involved in the first step of the inflam-
matory response, in the newly described PS bMEC line [22]. The MAC-T cell line barely
modifies its interleukin gene expression pattern when stimulated with pathogens, whereas the
PS cell line was shown to significantly react to stimulation, as illustrated by the secretion of IL-
8 in the presence of E. coli [22]. The PS cell line (INRA, Tours, France) was cultured at 37°C in
a humidified chamber with 5% CO2, in DMEM/F12 advanced medium (D. Dutcher) contain-
ing 10 mg/mL of IGF-1 (Peprotech), 5 ng/mL of FGF (Peprotech), 5 ng/mL of EGF (Sigma-
Aldrich), 1 μg/mL of hydrocortisone (Sigma-Aldrich), 20 mM of Hepes buffer (D. Dutcher)
and 2 mM of glutamine (Gibco).
Stimulation of PS cells was performed with LAB alone or with LAB in the presence of E.
coli, which is known to stimulate IL-8 production. Subsequent measurements of IL-8 produc-
tion were essentially performed as previously described [22]. PS cells were seeded at 2x104
cells/well in a 96-well plate and incubated for 72 h at 37°C (until cells formed a confluent
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layer). Cells were then cultured overnight (16 h) in fresh stimulating medium without growth
factors (PS stimulation medium). Cells were then washed twice with HBSS (Hank’s Balanced
Salt Solution; Sigma-Aldrich, Saint-Quentin Fallavier, France) and stimulated with either LAB
at a MOI of 100:1 or E. coli P4 at a MOI of 1:1, or both species. Cells were incubated for 3 h,
washed with HBSS and incubated in PS stimulation medium supplemented with 10 μg/mL of
gentamicin for 21 h, completing 24 h of infection. After this incubation, the supernatant was
collected and stored at -20°C until use. Concentration of IL-8 in the supernatant was measured
by ELISA as previously described [22]. All samples were analyzed in duplicate in two indepen-
dent assays (a total of four data points). IL-8 production by PS cells alone was used as a refer-
ence to assess the effect of LAB alone, whereas IL-8 production by E. coli-stimulated PS cells
was used as a reference to assess the effect of LAB in the presence of E. coli. Data were normal-
ized relative to these references.
Immunomodulation effects of LAB strains on HT-29 cell line
Experiments were performed as previously described [23]. Briefly, experiments were initiated
when HT-29 cells were at confluence (*1.83×106 cells/well). LAB were added at MOI 40:1 in
50 μL DMEM in a total volume of 500 μL. Cells were stimulated simultaneously with recombi-
nant human TNF-α (5 ng/mL; Peprotech, NJ, USA) for 6 h at 37°C in 10% CO2. Stimulation of
the HT-29 cell line with TNF-α alone was used as the reference condition. All samples were
analyzed in triplicate in three independent assays (a total of nine data points). After coincuba-
tion, cell supernatants were collected and mixed with anti-protease cocktail, as indicated by the
manufacturer (Complete, EDTA-free tablets, Roche) and frozen at −80°C until further analysis
of IL-8 concentrations by ELISA (Biolegend, San Diego, CA, USA).
Genome sequencing
Genomic DNA of L. brevis 1595, L. casei 1542, L. lactis 1596, and L. plantarum 1610 and 1612
was extracted and purified as described above. Genome sequencing, assembly and annotation
were performed as previously described [20]. Briefly, paired-end sequencing was performed
using HiSeq sequencing system (Illumina, San Diego, USA). Sequencing statistics are included
in S1 Table. Coding sequence (CDS) detection was performed with the Glimmer3 software
application [24]. Gene products were subjected to protein location prediction using the SurfG
software package [25]. Genomes were further screened using the CD-search tool of the Con-
served Domain Database for the presence of specific domains [26]. In particular, all genomes
were screened for the presence of domains involved in binding to mucin, collagen and fibro-
nectin: pfam06458 (MucBP, mucin-binding protein domain), cl05785 (MucBP superfamily),
pfam5737 (Collagen_bind, collagen-binding domain), pfam05738 (Cna-B, Cna protein B-type
domain;this domain is found in the Staphylococcus aureus collagen-binding surface protein,
but does not mediate collagen binding), cl15753 (collagenBindB superfamily), cl05349 (col-
lagen_bind superfamily), pfam07299 (FBP, fibronectin-binding domain), pfam05833 (FbpA,
fibronectin-binding protein A N-terminus), cl06363 (FBP superfamily), pfam00497 (SBP-bac-
3; bacterial extracellular solute binding proteins, family 3). Systematic analysis of the conserved
domain content of proteins annotated as Internalin was also included.
In addition, all genomes were screened for the presence of genes potentially encoding antibi-
otic resistance using the annotation tool of the Antibiotic Resistance Genes Database (ARDB;
http://ardb.cbcb.umd.edu/blast/genome.shtml). Genome sequences have been deposited at
DDBJ/EMBL/GenBank under the accession numbers LDEI00000000 (Lactobacillus brevis CIR-
M-BIA 1595), LDEJ00000000 (Lactobacillus casei CIRM-BIA 1542), LDEK00000000
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(Lactococcus lactis CIRM-BIA 1596), LDEL00000000 (Lactobacillus plantarum CIRM-BIA
1610), LDEM00000000 (Lactobacillus plantarum CIRM-BIA 1612).
Statistical analysis
Statistical analysis was performed using R software [27]. The differences in adhesion and inter-
nalization capacities among strains were assessed using one-way analysis of variance. Strains
were then grouped using Tukey’s range test. The capacity of LAB to modulate IL-8 production
by PS and HT-29 cells was assessed using the Mann-Whitney test.
Results
Isolation and identification of lactic acid bacteria within the bovine
mammary ecosystem
Sampling the teat canals of 20 cows on two farms led to the isolation and identification of 165
isolates. To avoid redundancy, a selection of these isolates was carried out considering only one
clone per species and per cow, ending up with a panel of 76 isolates. These isolates mainly cor-
responded to LAB, and included enterococci (28.9%), streptococci (28.9%), lactobacilli
(22.4%), and lactococci (6.6%). The remaining isolates corresponded to enterobacteria (9.2%)
and staphylococci (3.9%), which are not inhibited on the elective media used (S2 Table). Identi-
fication of these isolates based on 16S RNA analysis revealed that streptococcal isolates mainly
corresponded to species commonly associated with bovine mastitis (S. infantarius and S.
uberis) [1] and that enterococcal isolates are common fecal flora. We thus focused on the 22
isolates belonging to Lactococcus and Lactobacillus genera, which include one Lactococcus lac-
tis, four Lactococcus garvieae, four Lactobacillus brevis, 11 Lactobacillus plantarum and two
Lactobacillus casei isolates. At this step, the probiotic strain L. casei BL23 was also added to the
panel as a reference strain since this strain was previously shown to exhibit probiotic properties
[28] and we recently demonstrated that this strain was able to inhibit S. aureus internalization
into bovine MEC [12].
The 22 LAB isolates and L. casei BL23 were then characterized by PFGE (S1 Fig). All four L.
garvieae isolates belonged to the same cluster and, similarly, the two L. casei isolates had the
same PFGE profile. The 11 L. plantarum isolates fell into seven groups with unique PFGE pro-
files and the four L. brevis isolates corresponded to three unique PFGE profiles. Characteriza-
tion of the beneficial properties was then done on ten arbitrarily selected isolates
corresponding to unique PFGE profiles (i.e., corresponding to unique strains), to avoid any
risk of redundancy. The actual panel of strains thus includes one L. lactis, one L. garvieae, three
L. brevis, four L. plantarum and one L. casei isolates (in addition to L. casei BL23, used as the
control) (Table 1).
Characterization of inhibitory potential against pathogenic bacteria
None of the tested strains was found to produce hydrogen peroxide, as measured by the colori-
metric method on TMB agar plates (Table 1). Production of inhibitory compounds in the
supernatant was tested using the agar plate diffusion method (see Materials and methods for
details). Untreated supernatants of seven strains were able to inhibit, at least partially, the indi-
cator strains. All L. casei and L. plantarum strains inhibited growth of all the indicator strains
except that of S. aureus N305. On the contrary, no growth inhibition was observed for the L.
garvieae and L. brevis strains tested. An intermediate inhibitory capacity was observed for L.
lactis 1596. Inhibition was relieved in all cases when supernatants were neutralized with
NaOH.
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Surface properties of LAB isolated from the bovine mammary ecosystem
A great majority of strains (eight out of eleven) exhibited a low hydrophobicity
(MATH< 33%), whereas no strain was classified as highly hydrophobic (MATH> 66%).
Three strains had medium hydrophobicity (33%<MATH< 66%), namely L. plantarum 1610
and L. brevis 1595 and 1597. Autoaggregation capacities were low for all strains but one, L. bre-
vis 1597, which had a medium autoaggregation capacity.
Table 1. Characterization of surface and antagonistic properties of LAB strains isolated from bovine teat canal.
Name Sample Surface properties Antimicrobial properties
type Hydrophobicity Autoaggregation H2O2
production
Acidiﬁcation Diffusion test
Species CIRM-BIA % a Gr b % c Gr d TMB test pH SN f native SN g neutralized
SN g
Lactococcus
lactis
1596 Foremilk 21 L 10 L NP e 4.28 S. aureus RF122 / NB305,
E. coli LMA1678 /LMA1674
-
Lactococcus
garvieae
1605 Swab 7 L 7 L NP 4.45 - -
Lactobacillus
brevis
1613 Foremilk 25 L 8 L NP 5.25 - -
Lactobacillus
brevis
1595 Foremilk 46 M 15 L NP 5.23 - -
Lactobacillus
brevis
1597 Swab 35 M 66 M NP 5.09 - -
Lactobacillus
plantarum
1610 Foremilk 60 M 8 L NP 3.89 S. aureus RF122, E. coli
LMA1678/LMA1674, S.
uberis LMA1675/LMA1672
-
Lactobacillus
plantarum
1612 Foremilk 0 L 13 L NP 3.84 S. aureus RF122, E. coli
LMA1678/LMA1674, S.
uberis LMA1675/LMA1672
-
Lactobacillus
plantarum
1602 Foremilk 7 L 11 L NP 3.93 S. aureus RF122, E. coli
LMA1678/LMA1674, S.
uberis LMA1675/LMA1672
-
Lactobacillus
plantarum
1601 Swab 5 L 14 L NP 3.92 S. aureus RF122, E. coli
LMA1678/LMA1674, S.
uberis LMA1675/LMA1672
-
Lactobacillus
casei n
1542 Swab 6 L 14 L NP 4.10 S. aureus RF122, E. coli
LMA1678/LMA1674, S.
uberis LMA1675/LMA1672
-
Lactobacillus
casei BL23
10 L 13 L NP 4.17 S. aureus RF122, E. coli
LMA1678/LMA1674, S.
uberis LMA1675/LMA1672
-
a Percentage of hydrophobicity
b Strains were classiﬁed as low (L) or medium (M) according to their hydrophobicity capacities
c Percentage of autoaggregation
d Strains were classiﬁed as low (L) or medium (M) according to their autoaggregative capacities
e NP: non producer
f SN: supernatant
g Indicator strains inhibited by LAB supernatants in an agar plate diffusion test; “-”indicates that none of the indicator strains were inhibited.
doi:10.1371/journal.pone.0144831.t001
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Colonization potential of LAB
Adhesion capacities of LAB were highly strain-dependent, with differences between strains of
up to ~1.6 LOG10, independently of the MOI (Fig 1). Inter- and intra-species variability was
observed as illustrated for L. brevis and L. plantarum. Hence, at a MOI of 400:1, the adhesion
rate of L. brevis 1613 was 1.2x104 cfu per well (corresponding to 2.5x105 MAC-T cells), whereas
it reached 3.1x105 and 2.1x105 cfu per well for L. brevis 1595 and 1597, respectively. Likewise,
the adhesion rate of L. plantarum 1610 was 5x105 cfu per well, whereas it was ~2.7x104 cfu per
well for L. plantarum 1601 and 1612. Two strains, L. brevis 1595 and L. plantarum 1610,
Fig 1. Adhesion of lactic acid bacteria to bovine mammary epithelial cells. Lactic acid bacteria
populations that adhered to bMEC were determined after 1 h of interaction at a MOI of 400:1 (A) and 2000:1
(B), respectively. Data are presented as mean population per well (i.e., corresponding to 2.5x105 bMEC) ±
standard deviation. Each experiment was done in triplicate and differences between strains were assessed
using a one-way analysis of variance, followed by Tukey’s range test. Letters a, b, c and d indicate
homogeneous statistical processing groups that were significantly different according to Tukey’s range test.
doi:10.1371/journal.pone.0144831.g001
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exhibited adhesion capacities significantly higher than that of the others for a MOI of 400:1.
These trends were confirmed at a MOI of 2000:1 but differences between strains were
attenuated.
Internalization capacities of LAB were also highly strain-dependent, with differences of up
to 3 LOG10, independently of the MOI (Fig 2). Three strains, L. brevis 1595 and 1597 and L.
plantarum 1610, exhibited internalization capacities significantly higher than that of the others
at a MOI of 400:1. Hence, internalization rates of L. brevis 1595, 1597 and L. plantarum 1610 at
a MOI of 400:1 were 5.9x104, 4.7x104 and 1.0x105 cfu per well, respectively, whereas it was
between 1.5x102 and 5.0x103 cfu per well for the other strains. Differences were strongly
Fig 2. Internalization of lactic acid bacteria into bovinemammary epithelial cells. Lactic acid bacteria
populations internalized into bMECwere determined after 2 h of interaction at a MOI of 400:1 (A) and 2000:1
(B), respectively. Data are presented as mean population per well (i.e., corresponding to 2.5x105 bMEC) ±
standard deviation. Each experiment was done in triplicate and differences between strains were assessed
using one-way analysis of variance, followed by Tukey’s range test. Letters a, b, c and d indicate
homogeneous statistical processing groups that were significantly different according to Tukey’s range test.
doi:10.1371/journal.pone.0144831.g002
LAB and Bovine Mastitis
PLOS ONE | DOI:10.1371/journal.pone.0144831 December 29, 2015 10 / 18
attenuated at a MOI of 2000:1 since only L. brevis 1595 internalized at a significantly higher
rate compared to the others.
Of note, the cellular layer integrity was not affected by incubation with any of the LAB in
the conditions used: the MAC-T cells population remained constant at 2.5x105 cells per well,
and the cellular layer did not exhibit any changes in cell morphology during the experiment
(not shown).
Characterization of the immunomodulation potential of selected LAB
The capacity of LAB to modulate the production of the pro-inflammatory cytokine IL-8 was
assessed on the PS bMEC line by incubating either LAB alone with PS cells or LAB with E. coli-
stimulated PS cells. LAB alone at a MOI of 100:1 did not significantly affect IL-8 secretion by
PS cells (Fig 3). Immunomodulation properties of LAB occurred with E. coli-stimulated PS
cells. Hence, all strains but two led to a significant decrease of IL-8 secretion by PS cells, with L.
brevis 1595, 1597 and L. casei 1542 being the most efficient (2.8–2.9 fold decrease of IL-8 secre-
tion, pval< 0.05). Only L. plantarum 1601 and 1602 did not significantly affect IL-8 secretion
by E. coli-stimulated PS cells.
In a first attempt to evaluate immunomodulation properties of LAB, screening of LAB was
also done on the HT-29 model, which has been widely used to assess immunomodulation
properties of LAB in the human gut context [23] (S2 Fig). Using this model, L. garvieae 1605,
L. casei 1542 and, to a lesser extent, L. brevis 1595, were shown to slightly (1.1 to 1.4-fold), yet
significantly, stimulate the production of IL-8 in HT-29 cells, compared to IL-8 production in
the reference condition (HT-29 cells stimulated with TNF-α alone).
Genome sequencing, identification of proteins potentially exposed at the
cell surface and potential antibiotic resistance genes
The total genomes of five out of the ten LAB that were characterized, namely L. brevis 1595,
L. casei 1542, L. lactis 1596 and L. plantarum 1610 and 1612, were determined, leading to the
identification of 2429, 2760, 2339, 3091 and 3038 CDS, respectively. These strains were
selected for diversity purposes since they represent almost all species (except L. garvieae) and
exhibit different colonization and immunomodulation properties. L. garvieae was excluded
at this step as its safety status may be questionable [29]. Combining annotations of proteins
with their localization (PSE and secreted proteins) as well as the presence of specific con-
served domains allowed us to establish a list of proteins potentially involved in tissue coloni-
zation through their binding to cells or an extracellular matrix (collagen, mucin, fibronectin)
(S3 Table). All LAB strains, including BL23, encode three to six proteins containing a colla-
gen-binding domain and one or two proteins containing a fibronectin-binding domain. All
strains contain sortases, with up to four sortases for L. casei strains. On the contrary, strain-
to-strain variations occurred in the genomic content for MucBP domains, with three to four
proteins with a MucBP domain for L. brevis 1595 and L. plantarum strains, one for L. lactis
1596 and no protein with a MucBP domain in L. casei strains. Moreover, potential S-layer
proteins were only found in the L. brevis 1595 genome, whereas genes potentially involved in
capsular polysaccharide biosynthesis were present in L. casei 1542, L. lactis 1596 and L. plan-
tarum strains. All strains were also found to possess one or more proteins annotated as Inter-
nalin J precursor. However, the conserved domain content strongly varies between these
proteins (S3 Table).
The presence of potential antibiotic resistance genes was checked, revealing only a few
potential antibiotic resistance genes (S4 Table). Indeed, no gene encoding antibiotic resistance
genes was found in L. brevis 1595. All strains but one (L. brevis 1595) encode a potential
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bacitracin resistance gene. Finally, L. lactis 1596 was found to carry two additional genes poten-
tially coding for fluoroquinolone and tetracycline resistance.
Fig 3. Modulation of cytokine IL-8 production by LAB isolates. A: modulation of IL-8 production by the PS
cell line in the presence of LAB isolates (MOI 100:1). Bars represent the mean IL-8 production ± standard
deviation for four assays (two biological and two technical replicates), normalized with regard to IL-8
production by unstimulated PS cells (76 +/-16 pg/mL as a mean); B: modulation of IL-8 production by the E.
coli-stimulated PS cell line in the presence of LAB isolates. E. coliwas used at MOI 1:1 and LAB at MOI
100:1. Bars represent the mean IL-8 production ± standard deviation for four assays, normalized with regard
to IL-8 production by E. coli-stimulated PS cells (368 ± 88 pg/mL as a mean). Differences in IL-8 production
with regard to the reference condition were assessed using the Mann-Whitney test (* p < 0.05).
doi:10.1371/journal.pone.0144831.g003
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Discussion
Selection of potential probiotic strains
In this study, we isolated 165 clones from bovine mammary microbiota and did an in-depth
characterization of ten non-redundant LAB strains with regard to their beneficial properties in
a mammary gland context. During this sampling campaign, we isolated a majority of entero-
cocci (~29%: E. faecium and E. hirae) and streptococci (~29%: S. infantarius and S. uberis).
These species have been previously isolated from foremilk samples and are reportedly associ-
ated with mastitis and fecal contamination [8]. Of note, in our study, enterococci and strepto-
cocci were also mainly isolated from foremilk and after growth on M17. We thus focused our
study on LAB strains belonging to Lactococcus spp. (6.6% of the isolates) and Lactobacillus spp.
(22.4%) genera since they have a GRAS status and are already used as probiotics in specific
contexts.
As beneficial properties, we characterized LAB capacity to colonize mammary epithelial
cells in vitro, their inhibitory potential on three important bovine mastitis pathogens, and their
capacity to stimulate the innate immune system. In addition, the genomes of five of these ten
strains were fully sequenced, revealing interesting genetic determinants potentially linked to
the phenotypes observed and allowing potential utilization of strains devoid of antibioresis-
tance determinants. The five selected strains harbored only a few antibiotic resistance genes.
All strains but one (L. brevis 1595) show resistance to bacitracin, whereas L. lactis presented
two additional resistance determinants against tetracycline and fluoroquinolone, antibiotics
commonly indicated for intramammary or parenteral mastitis treatment in European countries
(S3 Table) [30–32]. Such a large screening of beneficial properties as well as of potential unde-
sirable genetic markers had never been done in this context before and allowed us to identify
LAB candidates that exhibited one or more promising properties for the prevention and/or
treatment of mastitis.
Competition for the niche
One important trait for probiotics is the ability to compete with pathogens for niche coloniza-
tion. We thus characterized the LAB strains with regard to their inhibitory potentials in terms
of acidification, production of hydrogen peroxide or other inhibitory compounds such as bac-
teriocin-like compounds and with regard to their colonization capacity. The ability of the ten
LAB isolates to inhibit the growth of representative strains of E. coli, S. uberis and S. aureus was
highly species-specific. The inhibition observed likely relied on acidification since neutraliza-
tion of the supernatants totally relieved their inhibitory activity. Supernatants of L. plantarum
and L. casei strains showed the highest inhibitory potential in relation to the lowest pH values.
However, we cannot totally exclude the production of inhibitory compounds such as bacterio-
cins which would be more active at low pH. Of note, in mammary gland, pH is close to neutral-
ity -respectively 6.89 and 6.71 for foremilk and stripping milk [33]. The impact of organic acid
production by LAB or other antibacterial compounds, which would be active at low pH, would
thus be limited. None of our ten LAB strains were found to produce hydrogen peroxide.
Hydrogen peroxide production is considered to be an interesting trait of vaginal probiotic LAB
[34]. It was also previously reported for some (but not all) LAB strains isolated from mammary
microbiota, although with a lower frequency than in vaginal LAB [8,35]. This might reflect a
different adaptation of LAB strains within mammary and vaginal ecosystems.
The ability to colonize tissues and, as a result, exert a prolonged beneficial effect and or com-
pete with pathogens for the niche is one of the criteria used to select a candidate probiotic
strain. Our results showed that adhesion capacities of LAB vary between strains. L. brevis 1595
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and 1597 and L. plantarum 1610 harbored the strongest adhesion to bMEC. These strains were
also those that had the highest hydrophobicity. Such correlation between adhesion and hydro-
phobicity had previously been reported [8]. One strain, namely L. brevis 1597, also exhibited
autoaggregation properties. Autoaggregation is thought to favor formation of protective bio-
film [35]. Autoaggregative strains may also titer pathogenic microorganisms by coaggregation
and facilitate their clearance [36].
Genomic comparison of strains exhibiting high (L. brevis 1595 and L. plantarum 1610) or
low adhesion rates (L. plantarum 1612, L. lactis 1596, L. casei 1542 and BL23) (S3 Table)
revealed differences in terms of genes potentially involved in host tissue colonization. Such var-
iations in adhesion determinants have already been reported in LAB and include several pro-
teins directly involved in adhesion to mucus, fibronectin or collagen, S-layer proteins or
proteins involved in capsular polysaccharide biosynthesis, as well as some house-keeping gene
products [6,37,38]. In our case, three to four MucBP domain proteins were found in strains
exhibiting high adhesion rates, whereas only one MucBP domain protein was found in L. lactis
1596 and none were present in L. casei genomes. Moreover, only L. brevis 1595 encodes S-layer
proteins and the presence of capsular polysaccharide biosynthesis genes was also strain-depen-
dent. Moreover, it is noticeable that L. brevis 1595 and the two L. plantarum strains, possess
two potential fibronectin-binding proteins, carrying the conserved domains FNB and FnbA,
respectively, whereas the low adhesive strains, except L. plantarum 1612, only possess one copy
of FbpA-domain protein. Whether the variations in adhesion capacities we observed in this
study are linked to the presence or absence of one or several of the above-mentioned adhesion
determinants remains to be explored.
Studies investigating LAB colonization capacity are generally restricted to the evaluation of
their adhesion properties, with the aim to prevent tissue colonization by pathogens. The capac-
ity to internalize and, possibly, to survive and proliferate within cells is classically associated
with pathogenic bacteria and, as a result, not explored for the so-called “beneficial bacteria”.
Only a few studies report LAB internalization, with the aim to use LAB as vehicles for intracel-
lular delivery of molecules [39]. In this study, LAB capacity to internalize into host cells was
investigated, showing strain-dependence. This ability was related to the ability to adhere, as
illustrated by a Pearson correlation coefficient of 0.89 between both capacities at a MOI of
400:1. Interestingly, full genome sequencing of the five strains revealed the presence of Interna-
lin J-like proteins, which share conserved domains with Listeria monocytogenes Internalin J
[40]. Of note, despite similarities with Internalin A and B, the exact function of Internalin J in
L.monocytogenes virulence is not yet fully understood [40]. The internalization capacity of the
tested LAB was limited compared to the one of two major etiologic agents of mastitis (S. aureus
and E. coli): internalized LAB population was similar to internalized S. aureus and E. coli popu-
lations using similar assays, but with a higher MOI for LAB compared to S. aureus and E. coli
(MOI of 400:1 and 2000:1 for LAB and MOI of 100:1 and 10:1 for S. aureus and E. coli respec-
tively) [12,41].Nevertheless, it raises questions about the possible persistence of LAB in tissue
and their effect on cellular physiology, cell cycle or epigenetic modifications, as observed with
pathogenic bacteria such as S. aureus [42]. This question requires further investigation.
Immunomodulation by bovine mammary LAB strains
On the one hand, a probiotic LAB candidate with a slight pro-inflammatory capacity can be of
interest to stimulate innate immunity and to thus prevent mastitis. On the other hand, a strain
with an anti-inflammatory capacity would help resolve the inflammation in infectious mastitis
and help the return to lactation. In this study, LAB did not significantly alter IL-8 production
by bMEC (PS line) when incubated alone with cells. In contrast, most LAB exhibited anti-
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inflammatory properties on E. coli-stimulated bMEC, where L. brevis 1595, 1597 and L. casei
1542 were the most efficient with a ~three-fold decrease of IL-8 production. We first attempted
to evaluate the immunomodulation properties of LAB on another well-known model, i.e., HT-
29, which has been widely used to evaluate these properties for LAB strains dedicated to gut.
Using this model, LAB did not exhibit similar immunomodulation properties (S2 Fig). Such a
discrepancy underlines the importance of using a cellular model relevant for the ecosystem
addressed. Some of the above-mentioned determinants that are putatively involved in adhesion
and internalization have also been correlated with the LAB immunomodulation properties
[37]. The involvement of these determinants in the immunomodulation properties will deserve
further experiments.
In conclusion, we have selected a set of LAB strains isolated from the bovine mammary
gland based on their PFGE pattern and screened them for their potential to colonize mam-
mary gland tissue and for their immunomodulation properties. Some strains present high in
vitro adhesion and invasion capacity and are potential candidates able to compete with path-
ogens for the colonization of mammary gland tissue and to exert prolonged beneficial effects.
Pro-inflammatory properties could help stimulate the innate immune system and promote
the clearance of pathogens. Anti-inflammatory properties could contribute to the decrease of
inflammation in association with or following antibiotic treatment. The presence of undesir-
able genetic elements such as antibiotic resistance genes was also checked in order to prevent
the risk of dissemination of antibiotic resistance determinants. These candidate strains
require further investigation to evaluate their barrier effect with regard to major mastitis
pathogens and their immune-modulatory potential on bovine mammary epithelial cells. The
mandatory experiments will be to assess in vivo safety and to challenge their efficacy in field
conditions.
Supporting Information
S1 Fig. Dendograms of PFGE patterns of Lactobacillus sp. (A) obtained with endonuclease
AscI and Lactococcus sp. (B) obtained with endonuclease SmaI. The similarities of the profiles
were calculated using Dice's coefficient and dendograms were obtained by the UPGMA cluster-
ing algorithm.
(TIF)
S2 Fig. Modulation of cytokine IL-8 production by the HT-29 cell line in the presence of
LAB isolates. Bars represent the mean IL-8 production ± standard deviation for three indepen-
dent assays, normalized with regard to IL-8 production when stimulation of the HT-29 cell line
was done with TNF-α alone (reference condition). Differences in IL-8 production with regard
to the reference condition were assessed using the Mann-Whitney test (# p< 0.1).
(TIF)
S1 Table. Sequencing statistics.
(DOCX)
S2 Table. Bacterial diversity of isolates from the bovine mammary gland. Total number of
isolates is indicated for each species/genus as well as the source of the isolates for each species
(i.e. cytobrush of teat canal or fore-milk sample) and the medium from which the isolates for
each species were selected.
(DOCX)
S3 Table. Potential bacterial determinants of LAB colonization capacities and immunomo-
dulation properties in L. brevis 1595, L. casei 1542, L. lactis 1696, L. plantarum 1610 and
LAB and Bovine Mastitis
PLOS ONE | DOI:10.1371/journal.pone.0144831 December 29, 2015 15 / 18
1612 and L. casei BL23.
(DOCX)
S4 Table. Potential antibiotic resistance genes encoded in L. brevis 1595, L. casei 1542, L.
lactis 1696, L. plantarum 1610 and 1612 and L. casei BL23.
(DOCX)
Acknowledgments
The sampling campaign was done in collaboration with Initiatives BioBretagne. We would like
to thank the dairies for allowing milk sample collection from their animals. We thank Gail
Wagman for revising the English.
Author Contributions
Conceived and designed the experiments: SE YLL PG FNM PL. Performed the experiments:
DSB BS TS LR PG CGMDB PF VC FC. Analyzed the data: DSB BS SE YLL JN. Wrote the
paper: SE DSB YLL.
References
1. Contreras GA, Rodriguez JM. Mastitis: comparative etiology and epidemiology. J Mammary Gland Biol
Neoplasia. 2011; 16: 339–356. doi: 10.1007/s10911-011-9234-0 PMID: 21947764
2. Le Marechal C, Thiery R, Vautor E, Le Loir Y. Mastitis impact on technological properties of milk and
quality of milk products-a review. Dairy Sci Technol. 2011; 91: 247–282.
3. Behnsen J, Deriu E, Sassone-Corsi M, Raffatellu M. Probiotics: Properties, Examples, and Specific
Applications. Cold Spring Harb Perspect Med. 2013; 3: a010074. doi: 10.1101/cshperspect.a010074
PMID: 23457295
4. Reid G, Kim SO, Kohler GA. Selecting, testing and understanding probiotic microorganisms. FEMS
Immunol Med Microbiol. 2006; 46: 149–157. doi: 10.1111/j.1574-695X.2005.00026.x PMID: 16487295
5. Even S, Bouchard D, Le Loir Y. Lactic acid bacteria to modulate virulence expression in pathogenic
bacteria: An alternative to killing? Interactive probiotics. CRC Press. Boca Raton, USA: Pessione E.
(Eds.); 2014. pp. 52–80.
6. Sengupta R, Altermann E, Anderson RC, McNabbWC, Moughan PJ, Roy NC. The role of cell surface
architecture of lactobacilli in host-microbe interactions in the gastrointestinal tract. Mediators Inflamm.
2013; 2013: 237921. doi: 10.1155/2013/237921 PMID: 23576850
7. Arroyo R, Martin V, Maldonado A, Jimenez E, Fernandez L, Rodriguez JM. Treatment of infectious
mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk.
Clin Infect Dis. 2010; 50: 1551–1558. doi: 10.1086/652763 PMID: 20455694
8. Espeche MC, Pellegrino M, Frola I, Larriestra A, Bogni C, Nader-Macias ME. Lactic acid bacteria from
rawmilk as potentially beneficial strains to prevent bovine mastitis. Anaerobe. 2012; 18: 103–109. doi:
10.1016/j.anaerobe.2012.01.002 PMID: 22261519
9. Klostermann K, Crispie F, Flynn J, Ross RP, Hill C, MeaneyW. Intramammary infusion of a live culture
of Lactococcus lactis for treatment of bovine mastitis: comparison with antibiotic treatment in field trials.
J Dairy Res. 2008; 75: 365–373. doi: 10.1017/S0022029908003373 PMID: 18680622
10. Frola ID, Pellegrino MS, Espeche MC, Giraudo JA, Nader-Macias ME, Bogni CI. Effects of intramam-
mary inoculation of Lactobacillus perolensCRL1724 in lactating cows’ udders. J Dairy Res. 2012; 79:
84–92. doi: 10.1017/S0022029911000835 PMID: 22077995
11. Frola ID, Pellegrino MS, Magnano G, Giraudo JA, Espeche MC, Nader-Macias ME, et al. Histological
examination of non-lactating bovine udders inoculated with Lactobacillus perolens CRL 1724. J Dairy
Res. 2013; 80: 28–35. doi: 10.1017/S0022029912000581 PMID: 23199568
12. Bouchard DS, Rault L, Berkova N, Le Loir Y, Even S. Inhibition of Staphylococcus aureus invasion into
bovine mammary epithelial cells by contact with live Lactobacillus casei. Appl Environ Microbiol. 2013;
79: 877–885. doi: 10.1128/AEM.03323-12 PMID: 23183972
13. Charlier C, Cretenet M, Even S, Le Loir Y. Interactions between Staphylococcus aureus and lactic acid
bacteria: an old story with new perspectives. Int J Food Microbiol. 2009; 131: 30–39. doi: 10.1016/j.
ijfoodmicro.2008.06.032 PMID: 18687499
LAB and Bovine Mastitis
PLOS ONE | DOI:10.1371/journal.pone.0144831 December 29, 2015 16 / 18
14. Vandevoorde L, Christiaens H, VerstraeteW. Prevalence of coaggregation reactions among chicken
lactobacilli. J Appl Bacteriol. 1992; 72: 214–219. PMID: 1568947
15. Riollet C, Rainard P, Poutrel B. Differential induction of complement fragment C5a and inflammatory
cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus. Clin Diagn
Lab Immunol. 2000; 7: 161–167. PMID: 10702487
16. Godon JJ, Zumstein E, Dabert P, Habouzit F, Moletta R. Molecular microbial diversity of an anaerobic
digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol. 1997; 63:
2802–2813. PMID: 9212428
17. Smith CL, Cantor CR. Purification, specific fragmentation, and separation of large DNAmolecules.
Methods Enzymol. 1987; 155: 449–467. PMID: 3431468
18. Lortal S, Rouault A, Guezenec S, Gautier M. Lactobacillus helveticus: strain typing and genome size
estimation by pulsed field gel electrophoresis. Curr Microbiol. 1997; 34: 180–185. PMID: 9009072
19. Juarez Tomas MS, Ocana VS, Wiese B, Nader-Macias ME. Growth and lactic acid production by vagi-
nal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli. J Med Micro-
biol. 2003; 52: 1117–1124. PMID: 14614071
20. Bouchard D, Peton V, Almeida S, Le Maréchal C, Miyoshi A, Azevedo V, et al. Genome sequence of
Staphylococcus aureusNewbould 305, a strain associated with mild bovine mastitis. J Bacteriol. 2012;
194: 6292–6293. doi: 10.1128/JB.01188-12 PMID: 23105046
21. Herron-Olson L, Fitzgerald JR, Musser JM, Kapur V. Molecular correlates of host specialization in
Staphylococcus aureus. PloS One. 2007; 2: e1120. doi: 10.1371/journal.pone.0001120 PMID:
17971880
22. Roussel P, Cunha P, Porcherie A, Petzl W, Gilbert FB, Riollet C, et al. Investigating the contribution of
IL-17A and IL-17F to the host response during Escherichia colimastitis. Vet Res. 2015.
23. Kechaou N, Chain F, Gratadoux JJ, Blugeon S, Bertho N, Chevalier C, et al. Identification of one novel
candidate probiotic Lactobacillus plantarum strain active against influenza virus infection in mice by a
large-scale screening. Appl Environ Microbiol. 2013; 79: 1491–1499. doi: 10.1128/AEM.03075-12
PMID: 23263960
24. Delcher AL, Bratke KA, Powers EC, Salzberg SL. Identifying bacterial genes and endosymbiont DNA
with Glimmer. Bioinforma Oxf Engl. 2007; 23: 673–679. doi: 10.1093/bioinformatics/btm009
25. Barinov A, Loux V, Hammani A, Nicolas P, Langella P, Ehrlich D, et al. Prediction of surface exposed
proteins in Streptococcus pyogenes, with a potential application to other Gram-positive bacteria. Prote-
omics. 2009; 9: 61–73. doi: 10.1002/pmic.200800195 PMID: 19053137
26. Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, et al. CDD: NCBI’s con-
served domain database. Nucleic Acids Res. 2014; doi: 10.1093/nar/gku1221
27. R development Core Team. R: A Language and Environment for Statistical computing. Vienna, Aus-
tria: R Foundation for Statistical Computing; 2013. Available: http://www.R-project.org
28. Mazé A, Boël G, Zúñiga M, Bourand A, Loux V, Yebra MJ, et al. Complete genome sequence of the pro-
biotic Lactobacillus casei strain BL23. J Bacteriol. 2010; 192: 2647–2648. doi: 10.1128/JB.00076-10
PMID: 20348264
29. Zuily S, Mami Z, Meune C. Lactococcus garvieae endocarditis. Arch Cardiovasc Dis. 2011; 104: 138–
139. doi: 10.1016/j.acvd.2010.05.005 PMID: 21402350
30. Suojala L, Kaartinen L, Pyörälä S. Treatment for bovine Escherichia colimastitis—an evidence-based
approach. J Vet Pharmacol Ther. 2013; 36: 521–531. doi: 10.1111/jvp.12057 PMID: 23679229
31. Suojala L, Simojoki H, Mustonen K, Kaartinen L, Pyörälä S. Efficacy of enrofloxacin in the treatment of
naturally occurring acute clinical Escherichia colimastitis. J Dairy Sci. 2010; 93: 1960–1969. doi: 10.
3168/jds.2009-2462 PMID: 20412909
32. ANSES. Assessment of the risks of emergence of antimicrobial resistance associated with modes of
antibiotic use in the field of animal health. 2014.
33. EspecheMC, Otero MC, Sesma F, Nader-Macias ME. Screening of surface properties and antagonistic
substances production by lactic acid bacteria isolated from the mammary gland of healthy and mastitic
cows. Vet Microbiol. 2009; 135: 346–357. doi: 10.1016/j.vetmic.2008.09.078 PMID: 19041199
34. Otero MC, Morelli L, Nader-Macias ME. Probiotic properties of vaginal lactic acid bacteria to prevent
metritis in cattle. Lett Appl Microbiol. 2006; 43: 91–97. PMID: 16834727
35. Nader-Macias ME, Otero MC, Espeche MC, Maldonado NC. Advances in the design of probiotic prod-
ucts for the prevention of major diseases in dairy cattle. J Ind Microbiol Biotechnol. 2008; 35: 1387–
1395. doi: 10.1007/s10295-008-0438-2 PMID: 18758837
LAB and Bovine Mastitis
PLOS ONE | DOI:10.1371/journal.pone.0144831 December 29, 2015 17 / 18
36. Younes JA, van der Mei HC, van den Heuvel E, Busscher HJ, Reid G. Adhesion forces and coaggrega-
tion between vaginal staphylococci and lactobacilli. PLoSOne. 2012; 7: e36917. doi: 10.1371/journal.
pone.0036917
37. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. Host interactions of probiotic bacterial surface mol-
ecules: comparison with commensals and pathogens. Nat Rev Microbiol. 2010; 8: 171–184. doi: 10.
1038/nrmicro2297 PMID: 20157338
38. Turpin W, Humblot C, Noordine M-L, Thomas M, Guyot J-P. Lactobacillaceae and cell adhesion: geno-
mic and functional screening. PloS One. 2012; 7: e38034. doi: 10.1371/journal.pone.0038034 PMID:
22675431
39. Innocentin S, Guimaraes V, Miyoshi A, Azevedo V, Langella P, Chatel JM, et al. Lactococcus lactis
expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes inter-
nalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol.
2009; 75: 4870–4878. doi: 10.1128/AEM.00825-09 PMID: 19482952
40. Bierne H, Sabet C, Personnic N, Cossart P. Internalins: a complex family of leucine-rich repeat-contain-
ing proteins in Listeria monocytogenes. Microbes Infect Inst Pasteur. 2007; 9: 1156–1166. doi: 10.
1016/j.micinf.2007.05.003
41. Dogan B, Klaessig S, Rishniw M, Almeida RA, Oliver SP, Simpson K, et al. Adherent and invasive
Escherichia coli are associated with persistent bovine mastitis. Vet Microbiol. 2006; 116: 270–282. doi:
10.1016/j.vetmic.2006.04.023 PMID: 16787715
42. Deplanche M, Filho RAE-A, Alekseeva L, Ladier E, Jardin J, Henry G, et al. Phenol-soluble modulin α
induces G2/M phase transition delay in eukaryotic HeLa cells. FASEB J Off Publ Fed Am Soc Exp Biol.
2015; 29: 1950–1959. doi: 10.1096/fj.14-260513
LAB and Bovine Mastitis
PLOS ONE | DOI:10.1371/journal.pone.0144831 December 29, 2015 18 / 18
